The RL and FL constructs bearing let-7 sites and BoxB sequences. To obtain Renilla luciferase (RL) expression from a CMV promoter, the RL coding region was released from phRLTK (Promega) as a NheI-BamHI fragment and inserted into similar sites in the pCIneo vector (Promega) to get pRL-Con. Note that this RL gene contains optimized codon usage (humanized) for better expression in mammalian cells. To make RL reporters whose expression is controlled by endogenous let-7a RNA, we inserted annealed primers into the XbaI-NotI sites of pRL-Con to get constructs having one perfectly base-pairing (ACTATACAACCTACTACCTCA; pRL-Perf), one bulged (GCACAGCCTATTGAACTACCTCA; pRL-1xBulge), three bulged (GGACAGCCTATTGAACTACCTCACTCGGAGCACA GCCTATTGAACTACCTCAGGCCTGCACAGCCTATTGAACTACCTCA; pRL3xBulge) and three mutated bulged (GCACAGCCTATTGAACTACCCCTCAC TCGAGCACAGCCTATTGAACTACCCCTCAGGCCTGCACAGCCTATTGAACTA CCCCTCA: pRL-3xBulgeMut) let-7 sites in the 3'UTR. The mutated bulged binding sites have a 2-nt insertion (underlined) in the seeding region of the bulged let-7 complementary site. We verified that this mutation abolishes the repressive effect of endogenous let-7 RNA on translation of the RL reporter (figs. S9B and C). To obtain firefly luciferase (FL) constructs with let-7 complementary sequences, we initially modified the pGL3 Promoter plasmid (Promega) by insertion of a T7 RNA polymerase promoter into the HindIII site upstream of the FL ORF. The resulting plasmid was named pFL-Con. To obtain pFL-Perf and pFL-3xBulge, containing one perfect and three bulged let-7 sites, respectively, the corresponding XbaI-HpaI fragments were excised from the 3'UTR regions of pRL-Perf and pRL-3xBulge and inserted to corresponding sites of 1 pFL-Con. A derivative of pRL-Con, pRL-5BoxB, containing 5 BoxB hairpins in the 3'UTR, was described before (S1).
pFL-Con. A derivative of pRL-Con, pRL-5BoxB, containing 5 BoxB hairpins in the 3'UTR, was described before (S1).
To generate control plasmids used in ER-targeting experiments, plasmids pRLCon, pRL-5BoxB and pRL-3xBulge were modified by inserting appropriate annealed oligonucleotides into the NheI site, upstream of the RL ORF. These plasmids (HA-RL series) allow for expression of RL with an N-terminal HA tag. To achieve ER-targeting, sequences encoding a fusion of the calreticulin signal peptide (MLLSVPLLLGLLGLAVADRSHTGGMAYPYDVPDYA; the signal peptide sequence is underlined) with the HA tag were inserted into the N-terminal region, and sequences encoding an ER retention signal KDEL were inserted into the C-terminal region of the protein (ER-HA-RL plasmid series).
IRES constructs.
To obtain pEMCV-FL-Con, a BamHI-NcoI fragment containing the T7
promoter and the EMCV IRES was excised from the plasmid pCREL (S2) and inserted into the HindIII-NcoI sites, upstream of the FL ORF in pFL-Con. Similarly, the same BamHI-NcoI fragment was inserted into the BglII-NcoI sites upstream of the RL ORF in phRL-TK (Promega) to yield pEMCV-RL-Con. To obtain pEMCV-FL-3xBulge and pEMCV-RL-3xBulge, the 3'UTR fragment containing the 3xBulge region was released from pRL-3xBulge as an XbaI-BamHI fragment and inserted into similar sites of pEMCV-FL-Con and pEMCV-RL-Con, respectively. To generate pHCV-FL-Con, we pFL-2BoxB and pFL-6BoxB were cloned into the NheI site, upstream of the RL ORF in phRL-TK (Promega). In the resulting plasmids, the distance between the termination codon of the upstream FL cistron and BoxB hairpins is 95 nt, and that between BoxB haipins and the downstream RL cistron ATG is 75 nt. Finally, the let-7 sites sequences were inserted into the RL 3'UTR as described above.
The mutant version of the human eIF4GI (amino acids 612-1560, Accession no.
AF104913) used in this study lacks the eIF4E-interaction potential but retains capacity to drive productive translation when tethered to a reporter mRNA (S4) . For expressing the NHA-fusion of the eIF4GI mutant, the required coding region was PCR amplified from the plasmid pcDNA3-HA-eIF4GI (S5) and inserted into EcoRI-NotI sites of the pCIneo λN-HA vector (S1). The mutant form of mouse eIF4E that lacks the cap-binding activity (in this mutant the three-amino-acid sequence PMW at positions 100-102 is replaced by valine; Accession no. NM_007917), is similar in phenotype to a W102L mutation described previously (S6) . The eIF4E mutant was kindly provided to us by Dr. N.
Sonenberg of McGill University, Montreal. Correctness of all plasmids was verified by
sequencing. Additional details of cloning and plasmid sequences are available on request.
Other plasmids: Constructs expressing NHA-fusions of LacZ, hAgo2, hAgo4 and the ΔPRP deletion mutant of hAgo2, and the HA-tagged version of hAgo2 were described earlier (S1). A construct expressing the NHA-tagged hAgo3 (Accession no. AK022827) was made by inserting the coding region of the protein into the pCIneo NHA vector (S1).
Plasmid expressing Dcp1a-GFP was described before (S7) .
In vitro transcription and analysis of RNA
All plasmids were linearized with HpaI and transcribed in vitro by the T7 RNA polymerase, using either the Message Machine kit or the Megascript transcription kit (Ambion) to generate m 7 G-capped or non-capped RNAs, respectively. Subsequently, RNAs were treated with DNase I and polyadenylated using the Escherichia coli poly(A) polymerase (Ambion) according to manufacturer's protocol. Subsequently, the RNA was purified using the Absolutely RNA Miniprep kit (Stratagene). To verify quality and size of the RNAs, they were electrophoresed on a 1% agarose gel under denaturing conditions, and either visualized under UV or subjected to Northern analysis using 32 Plabelled random-primed probes specific for RL or FL coding regions. The length of the poly(A) tail was estimated as approximately 250 residues, as based on a comparsion with the RNA Century Marker (Ambion), run in parallel. RNA concentrations measured by the UV absorption at 260 nm were occasionally readjusted taking into account the PhosphorImager (Molecular Dynamics) quantification of Northern blots (the probes used for hybridization were complementary to the coding region, which is identical in different RNA forms). Activity of all in vitro synthesized RNAs was determined by translation in the wheat germ extract or the rabbit reticulocyte lysate (both from Promega) according to manufacturer's instructions. Luciferase activities were measured using the DualLuciferase Assay kit (Promega). RNA transfection experiments were reproduced with the two independent preparations of in-vitro-synthesized RNAs.
Transfections
HeLa, HEK293, Huh7 and HepG2 cells were grown in Dulbecco's modified Eagle's medium (Gibco-BRL) supplemented with L-glutamine (2 mM) and 10% heat-inactivated fetal calf serum (FCS), and maintained using standard protocols. HeLa or HEK293 cells were transfected using Lipofectamine Plus as suggested by the manufacturer. All plasmids used for transfection were prepared using the Maxiprep kit (Qiagen). Unless indicated otherwise, HeLa cells were grown in a monolayer in 6-well plates and 100 ng per well of the reporter plasmid was co-transfected with 50 ng of either pFL-Con or pRLCon, serving as normalization controls. When RNA was subjected to Northern analysis, an additional 75 ng of a GFP-expressing plasmid was co-transfected to serve as an mRNA level normalization control. When indicated, 2'-O-Me antisense oligonucleotides complementary to either let-7a RNA (UCUUCACUAUACAACCUACUACCUCAACCUU) or the liver-specific miRNA miR-122a (UCUUCACAAACACCAUUGUCACACUCCAACCUU; both from Microsynth) were co-transfected at a final concentration of 100 nM. The let-7Mut and wild-type let-7 siRNA-like duplexes had following sequences: let-7Mut (sense UGAGGGGUGGUAGGUUGUCUG, antisense GACAACCUACCACCCCUUAUU) and let-7 wild-type (sense UGAGGUAGUAGGUUGUAUAGU, antisense UAUACAACCUACUACCUUAUU). For DNA transfections, the results are represented as means of three transfections, with one of the conditions (as indicated in the figure legends) set to 1, +/-SD. For DNA transfections, the cells were lysed for luciferase activity measurements 48 h post-transfection. When required, the proteasome inhibitors MG132 and Z-Leu-Leu-Leu-al (both from Sigma) were added to the cell culture medium 4-6 h prior to lysate preparation at final concentrations of 50 μM.
For RNA transfections, the indicated amounts of RNA were transfected into HeLa cells using Lipofectamine Plus or Lipofectamine 2000. Cells were harvested 6 h posttransfection and luciferase activities were measured. All transfection experiments, with both DNA and RNA, were always done in triplicates and repeated at least 3 times.
Stably transfected cells and cell lines
HeLa cells were grown in a monolayer in 10 cm dishes and transfected with plasmids pRL-3xBulge, pRL-3xBulgeMut, pCIneo HA-Ago2, pCIneo NHA-Ago2 or pCIneo NHA-Ago3, using Lipofectamine as recommended by the manufacturer. Two days posttransfection, cells were split into a 15 cm plate and selection carried out in the presence of 500 μg/ml of G418 for 16 days. Single colonies were isolated for stably transformed cells expressing HA-Ago fusions and expression of proteins was confirmed by Western analysis with anti-HA antibodies. For cells expressing RL reporters, pools of stablytransformed cells were prepared and analyzed for RL protein and mRNA levels by using luciferase activity assay and RT-PCR, respectively. All stable clones and pools were maintained in media containing 300 μg/ml of G418.
Polysome analysis
For the hAgo2 tethering experiments, HeLa cells were grown in 10 cm plates and cotransfected, using Lipofectamine, with 1 μg of pRL-5BoxB and 3 μg of the plasmid another 24 h to maintain them in active growing conditions. Aliquotes of cells were always removed and grown in a well of a 6-well plate; these cells were used for activity measurements to confirm the degree of repression, prior to lysate preparation. When indicated, the cells were pre-treated with either 30 mM NaF (S8) or 10 μM of homoharringtonine (Sigma) (S9) for 25 min before lysate preparation. The lysate preparation and sucrose gradient centrifugation were as described previously (S8) .
Briefly, cells were treated with 100 μg/ml of cycloheximide for 5 min, followed by washes with phosphate-buffered saline (PBS) and a hypotonic buffer (5 mM Tris-HCl, pH 7.5, 1.5 mM KCl, 2.5 mM MgCl 2, 100 μg/ml cycloheximide). Lysates were prepared by scrapping the cells in lysis buffer [hypotonic buffer containing 0.5% deoxycholate, 0.5% Triton X-100 and 120 U/ml of Rnasin (Promega)]. In an alternative procedure, cells
were collected by scrapping in PBS, transferred to Eppendorf tubes for additional washes and lysed in the lysis buffer containing 200 μg/ml of yeast tRNA. Lysates were centrifuged for 8 min at 3,000 x g at 4°C and supernatants were then layered onto 10-50% sucrose gradients and spun in an SW40 rotor (Beckman) at 36,000 rpm for 2 h at 4°C. Twelve fractions were collected, treated with Proteinase K, and RNA extracted with phenol/chloroform and precipitated with ethanol. RNA samples were treated with DNase I, extracted again with phenol/chlorofoam and precipitated. Northern analysis was as described earlier (S1). 32 P-labelled probes were prepared using the random priming kit (Roche) and fragments of RL, FL, and mouse β-actin cDNAs as templates
Sub-cellular fractionations
For preparation of ER-enriched fractions, HeLa cells were transfected with 3 μg of either pHA-RL-5BoxB or pER-HA-RL-5BoxB per 10 cm plate and further split into 15 cm plates as described above. ER membrane fractions were prepared essentially as described (S10) . Briefly, cells were harvested by scraping in PBS and disrupted by douncing in a hypotonic buffer. After centifugation at 1,000 x g for 5 min, the collected supernatants were layered on a 1 ml cushion of 1.3 M sucrose and centrifuged at 14,000 x g in a SW60
Beckman rotor for 2 h at 4°C. The top cytosolic phase and the white interphase To detect miRNAs, 10 μg of total RNA prepared from cells or cell fractions was resolved by denaturing PAGE and electroblotted using the semi-dry blotter (Bio-Rad).
Oligodeoxynucleotides complementary to miR-122a and let-7a were 5'-end-labeled, using T4 polynucleotide kinase and [γ-32 P]ATP, and used as probes for Northern analysis.
Immunoprecipitations and Western analysis
Cells were extracted with Buffer C (see above) containing 150 mM KCl and 0.5% Triton X-100 on ice for 15 min and supernatants were obtained by centrifugation at 14,000 x antibodies except anti-Xrn1 were used at 1:1,000 dilutions; anti-Xrn1 was used at 1:500 dilution. Rabbit anti-hAgo2 (a kind gift of T. Hobman, University of Alberta, Edmonton), raised against a recombinant hAgo2 protein fragment, was used at 1:1,000 dilution. Note that this antibody cross-reacts with the other three human Ago proteins.
Immunofluorescence
For immunofluorescence (IF) analysis, HeLa cell lines were grown in 6-well plates.
When required, HeLa or HEK293 cells were transfected with the plasmids expressing HA-tagged Ago fusion protein, using Lipofectamine Plus. 24 h post-transfection, cells
were transferred into 8-well-chambers (Falcon) and grown for another 24 h. Cells were fixed in 10% formalin for 15 min at room temperature, washed with PBS and permeabilized and "blocked" for 30 min with a blocking buffer (PBS with 5% normal goat serum), containing 0.2% Triton X-100. The cells were then incubated for 2 h with primary antibody diluted in a blocking buffer, washed (3 x 5 min), and incubated with the secondary antibody for 30 min. The cells were again washed with PBS (3 x 5 min), stained with DAPI and mounted in antifade (Mowiol; Hoechst). Samples were visualized using a 100x objective of an Olympus IX70 fluorescence microscope and digitized images were taken with a photonics CH350/L CCD camera (Photometrics; Deltavision SGI System). Wide-field images were deconvoluted and processed using the Bitplane/Imaris programme. The antibodies used were: rat anti-HA mAb 3F10 (1:100 dilution), rabbit anti-hDcp1a and anti-Xrn1 (each at 1:200), rabbit affinity-purified antihLsm1 and anti-hLsm4 (S11) (both at 1:400; kindly provided by R. Lührmann, MaxPlanck Institute of Biophysical Chemistry, Göttingen). Secondary antibodies were:
chicken Alexa-Fluor 488 anti-mouse IgG, goat Alexa-Fluor 488 anti-rabbit IgG, and goat Alexa 594 anti-rat IgG (Molecular Probes); all used at 1:500 dilution.
In situ hybridizations and microinjections
HeLa cells were transfected, by the calcium-phosphate co-precipitation procedure, with 1 μg of Dcp1a-GFP, 2 μg of the RL reporter plasmid, and 7 μg of a carrier plasmid. 16 h post-transfection, cells were split onto glass coverslips, and fixed 24 h later. Antisense 2'-O-Me oligonucleotides (final concentration 100 nM) were included in some transfections as indicated.
In situ hybridizations for RL mRNAs were done with a mixture of fluorescent complementary oligonucleotides as described previously (S12), except that formamide concentration was raised to 50% during hybridization and washes. The oligonucleotides had the following sequences:
RL1: 5' aT*AgtccagcacgtT*catttgcttgcagT*gagcccaccactgaT*a; RL2: 5' aT*tagctggaggcagcgT*taccatgcagaaaaaT*cacggcgttT*a; RL3: 5' aT*cacaaagatgatT*ttctttggaaggtT*cagcagctcgaaccaagT*a; RL4: 5' aT*aatagcgttggaaaagaaT*ccagggtcggacT*cgatgaacatT*a.
Residues marked as T* correspond to the amino-modified thymidines that were conjugated to Cy3.
In situ hybridizations for let-7 and miR-122a RNAs were done with either locked nucleic acid (LNA; Exiqon) or RNA probes complementary to let-7a and miR-122a
RNAs, respectively. RNA probes were synthesized by the in vitro T7 RNA polymerase transcription, using appropriate linearized DNA templates and a mixture of UTP and digoxigenin-UTP (DIG-RNA-labeling kit; Roche). The probes were purified on Quickspin columns (Roche). The resulting miR-122a probes had following sequences:
GGGAGCUCUUUCAAACACCAUUGUCACACUCCAUUUAAG (miR-122a probe), GGGAGCUCUUUCAAUGUGGAUUGUCACACUCCUUUAAG (mutant miR-122a probe), and GGGAGCUCUUUAGAUAUUUAGUGUGAUAAUGGCGUUUGAUGGUUUGGACU UUAAG (pre-miR-122a probe; the underlined regions are complementary to the mature miR-122a or a precursor-specific region, and mutated bases in the miR-122a mutant probe are shown in bold).
LNA oligonucleotides were labelled with digoxigenin, using terminal transferase 3'-DIG-tailing kit (Roche), and were purified on a Quickspin column. The let-7 LNA probes had following sequences: AACUAUACAACCUACUACCUCA (for let-7a), AACAUAUCAACCAUCAUCCUCA (for let-7a mutant; mutations are in bold), and UAUCUCCCAGUGGUGGGUGUGA (for pre-let-7a, the sequence is complementary to pre-let-7 RNA nucleotide positions 34-55).
LNA and RNA probes were hybridized as described above, except that formamide concentration was set to 30% during hybridization and washes. Digoxigenin revelation was done as described previously (S13).
Cy3-labelled pre-let-7 RNA fused to the hammerhead ribozyme was synthesized in vitro as previously described (S14), using a PCR product as template (S15, S16). The fusion RNA undergoes efficient self-processing to yield pre-let-7 RNA containing authentic 5' and 3' termini (S15, S16). The RNA was purified on a Quickspin column, diluted in PBS, and injected alone or with wheat germ agglutinin (WGA) to HeLa cell nuclei as described previously (S14). Pictures were collected 1 h post-injection.
Processing of pre-miRNAs to mature miRNAs occurs in the cytoplasm and is catalyzed by Dicer. Neither the endogenous nor ectopically expressed form of this enzyme co-localizes with PBs [(S17); and data not shown], arguing against the possibility that the observed localization of the microinjected RNA in PBs represents the premiRNA processing site rather than the site of sequestration of translationally inhibited mRNPs.
Images were captured with a coolsnap CCD camera (Roper Scientific), on a DMRA microscope equipped for epi-fluorescence (Leica) with a 100x objective (Planapo, NA 1.4), and controlled by Metamorph (Universal Imaging). Single plane images were then deconvoluted with the Huygens software (Bitplane) and mounted with
Photoshop. Images shown in Fig. 3 , and figs. S10, S11 and S14 represent fields of 51 x 51 μm. The insets show an enlargement of an indicated region (3 x 3 μm), which is representative of cellular localization of RL or let-7 RNA and Dcp1a. To facilitate visualization of the images, the contrast was adjusted differently between the RL3xBulge and the RL-3xBulgeMut samples or between RL-3xBulge and RL-Perf samples.
After deconvolution, the foci present in the RL-3xBulge samples were 5-20 times more intense than the spots seen in the RL-3xBulgeMut or RL-Perf samples. The RL3xBulgeMut and RL-Perf spots probably correspond to single mRNA molecules, while the 3xBulge foci appear to concentrate many mRNA molecules (see also legend to fig.   S11 ).
Method for estimating the amount of let-7 RNA and RL mRNA in Dcp1 foci.
Deconvolved images were thresholded to remove background signals. For let-7, the background was estimated from neighboring non-injected cells. Typically, the threshold values were low, about 5% of the maximal signal intensities. This ensured that most of the let-7-specific signal could be included in the analysis. Then, the thresholded Dapi image was used to create a mask, which was applied on the thresholded let-7 image to remove the signals originating from nuclear RNAs. The total amount of signal in the resulting let-7 image was then calculated, yielding the amount of cytoplasmic let-7 in this image. The thresholded Dcp1 image was also used to create a mask, which was applied on the previous let-7 image to eliminate the let-7 signal not co-localized with Dcp1. The amount of let-7 signal in the resulting image was then calculated, yielding the amount of let-7 co-localized with Dcp1. This number was then divided by the amount of cytoplasmic let-7 to estimate the fraction of cytoplasmic let-7 RNA present in Dcp foci.
To estimate the amount of co-localization occurring by chance, the same analysis was performed with sets of let-7 and Dcp1 images originating from different cells. For each of these unmatched let-7/Dcp1 couples, the cells were first aligned. This was done by first centering their nuclei, and then rotating the cells to align their longest axis.
The procedure for quantifiying RL mRNA co-localization with Dcp1a was the same as that for quantifying let-7 RNA in Dcp1 foci. The thresholds used to create the Dcp1 masks were almost identical for RL-3xBulge and RL-3xBulgeMut mRNAs: they averaged to 4.6% and 4.5% of the maximal values in the images, respectively. These low thresholds ensured that RL mRNAs adjacent to Dcp1 foci could be counted as present within the foci. 
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None Anti-let-7 Anti-miR-122a and with a plasmid expressing GFP-Dcp1a. Other details were as described above. Note that the same cell lysates were used for IPs shown in both panels and that ΔPRP mutant migrates in the gel with mobility similar to that of the full-length protein (S1). RNA has no effect on RL activity. antibody. The boxed region shows a zoomed section highlighting colocalization of the RNA with Dcp1a. Table S1 . Fr action of cytoplasmic let-7 RNA and RL reporter mRNAs colocalized with Dcp1a in PBs. The fraction of cytoplasmic RNA present in PBs was measured as described in the Materials and Methods. The numbers represent means (+/-SD) for at least 10 cells from experiments similar to those described Anti-miR-122a 75.7 (n=111) Table S3 . Amount of let-7 and RL-3xBulge mRNA foci adjacent to or perfectly overlapping with PBs. The data are derived from experiments similar to those shown in Fig. 3 and fig. S10 , and are based on analysis of 14 and 10 cells for let-7 and RL-3xBulge RNAs, respectively. 
